SEQENS
Entity

  • SEQENS

    Created in 2003


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    381 573 45,874

  • Entity types

    Large company

  • Location

    21 Chem. de la Sauvegarde, 69130 Écully, France

    Écully

    France

  • Employees

    Scale: 1001-5000

    Estimated: 1,322

  • SIREN

    444465736

  • Engaged catalyst

    42
    0 0

  • Added in Motherbase

    4 years, 4 months ago
Description
  • Value proposition

    Our science for your future

    SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients.

    The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

    SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.


    Pharmaceutical Synthesis, Specialty Ingredients, Cosmetics, Custom Specialties, R&D, CDMO, CRDO, Generics, Innovative Pharmaceuticals, and Personnal Care

  • Original language

    Our science for your future

    Seqens est un leader mondial de la synthèse pharmaceutique et des ingrédients de spécialité.

    Le groupe génère un chiffre d'affaires de 1.1 milliard d'€ et exploite 16 sites de production ainsi que 9 centres de R&D en Europe, en Amérique du Nord et en Asie. 3 300 collaborateurs contribuent au succès de Seqens, parmi lesquels plus de 350 scientifiques, ingénieurs et experts qui développent des solutions sur mesure pour nos clients.

    Seqens est un acteur intégré qui offre un large portefeuille de principes actifs, d'intermédiaires pharmaceutiques et d'ingrédients de spécialité. Nous développons et industrialisons les molécules les plus exigeantes, en prenant appui sur notre capacité à innover, à développer et à mettre en œuvre les meilleures technologies disponibles.

  • Pharmaceutical Solutions, Personal Care & Specialty Ingredients - SEQENS

    SEQENS is an integrated global leader in Health, Personal Care and Specialty Ingredients with 16 production sites and 9 R&D centres across the world,

    • https://www.seqens.com/
Catalyst interactions
Catalyst TypeTweets Articles
Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing 		Other

21 Oct 2019

9 Jun 2025



Solvay
Solvay
Chemistry, Chemical Manufacturing
Solvay
Chemistry, Chemical Manufacturing 		Other

17 Jun 2023


Social network dynamics
Last news
Show all articles